| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Niagen Bioscience, Inc. (NAGE) has 8 insiders with recent SEC Form 4 filings, including 8 buys and 3 sells. NAGE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 20.0K | $84.0K | - | |
| Dir | 20.0K | $84.0K | - | |
| Dir | 20.0K | $84.0K | - | |
| Dir | 20.0K | $84.0K | - | |
| Dir | 20.0K | $84.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 31, 2023 | Fried Robert N51 | Chief Executive Officer | Buy | 7,000 | $1.42 | $9,940.00 | +8.0% | +11.3% | +100.7% | |
| May 25, 2023 | Rubin Steven D67 | Director | Buy | 7,000 | $1.46 | $10,220.00 | New | +2.1% | +118.2% | |
| Sep 30, 2022 | Fried Robert N51 | Cheif Executive Officer | Buy | 80,000 | $1.25 | $100,000.00 | +9.0% | +31.7% | +18.7% | |
| Sep 30, 2022 | Chau Hoi Shuen Solina Holly61 | 10% Owner | Buy | 960,000 | $1.25 | $1,200,000.00 | +13.9% | +31.7% | +18.7% | |
| Jun 16, 2022 | Chau Hoi Shuen Solina Holly61 | 10% Owner | Buy | 60,037 | $1.66 | $99,877.55 | +0.9% | -11.6% | +2.4% | |
| Mar 16, 2022 | Fried Robert N51 | CEO | Buy | 25,000 | $2.16 | $54,000.00 | +39.7% | -17.1% | -24.9% | |
| May 13, 2021 | Fried Robert N51 | CEO | Buy | 10,000 | $6.65 | $66,500.00 | +18.9% | +30.2% | -74.6% | |
| Mar 16, 2021 | Block Stephen A | Director | Sale+OE | 52,500 | $11.92 | $625,775.00 | -61.2% | -20.1% | -83.3% | |
| Dec 10, 2020 | Jaksch Frank L Jr | Executive Chairman Of Board | Sale+OE | 37,829 | $5.19 | $196,332.51 | -14.4% | - | - | |
| Nov 6, 2020 | Farr Kevin M69 | Chief Financial Officer | Buy | 5,000 | $4.43 | $22,150.00 | +13.7% | - | - |